approving a new drug some are calling fiagra. some women say it s long overdue. we re joined this morning by a doctor. doctor, good to see you. good to see you, jose. tell us why it s taken so long for this drug to get to this stage. well, there are a few different issues here. in terms of women s physiology, it seems to be more complicated in this area. there are physical factors, emotional factors and psychological factors as well. when scientists have tried this in the past, they tried testosterone, estrogen hormonal replacements and they haven t been as effective. they tried viagra also, and that wasn t as effective. but fiagra is something they re trying and they hope it can be effective. how is it different? it works on the brain. viagra works more on performance. you take it right before you
women to have their own libido-enhancing drug? we re waiting, right now, in fact, for the fda to tell us whether the so-called female viagra will be approved. we re looking at what many are saying is a disparity, like a focus on men s libido and women have kind of been left hanging. . he ll have his very own personal assistant. and this guy won t just surf the web. he ll touch it. scribble on it. and share it. because these kids will grow up with windows 10. get started today. windows 10. a more human way to do. [ female announcer ] everything kids touch at school sticks with them. make sure the germs they bring home don t stick around. use clorox disinfecting products.
keir simmons, nbc news, london. what a great story. i wish i had that when my girls were little girls were babies. keir simmons, thanks. after the break, the so-called female viagra could be one step closer to becoming reality. i ll speak to a doctor about the impact this could have on women. check out this guy. arizona rattlers dance team took to the field and one of the players look like a dancer. it turns out he s not a dancer but a real life choreographer. but very cool. d this guy won t t surf the web. he ll touch it. scribble on it. and share it. because these kids will grow up with windows 10.
senior medical correspondent elizabeth cohen joins me now from washington. elizabeth this seems to be a very real problem for women like cindy there. so why why did this panel vote against the drug s approval? they said, don, that the data just wasn t there. they said in the studies on average, women like cindy who took the pill had one more sexually satisfying event. that was the scientific term, per month than when they didn t take it. they said one more sexually satisfying event per month might have been a placebo effect and the drug had a side effect. some women felt dizzy or nauseous and when they weighed it they said the evidence is not there to put it on the market and this is not the first so-called female viagra that s been rejected. so now there s a concern that the pharmaceutical companies are not going to want to sink a lot of money into it. that s what i was going to ask you. is it back to the drawing board?
now when you open and fund an account, you ll get 200 commission-free trades. fidelity investments. turn here. welcome back, everyone, stocks ended higher this week after skyrocketing gold prices lifted shares of mineral companies. the value of gold rose to about 1258 an ounce friday and analysts speculate it could top 1,300 in the months to come. gold prices have risen about 12% since january as traders look for assurances that the economy is back on track. there s been a major set back for the makers of the drug that s being called the female